BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35272427)

  • 21. Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection.
    Li XH; Zhou EL; Zhao CY; Cui BK; Dong XY; Du H; Lin XJ
    Cancer Med; 2023 Dec; 12(24):21742-21750. PubMed ID: 38059559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study.
    Li Q; Chen C; Su J; Qiu Y; Wu H; Song T; Mao X; He Y; Cheng Z; Li J; Zhai W; Zhang D; Geng Z; Tang Z
    BMC Cancer; 2022 Mar; 22(1):329. PubMed ID: 35346122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
    Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
    JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
    Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
    Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
    Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
    Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study.
    Zhang Z; Zhou Y; Hu K; Wang D; Wang Z; Huang Y
    BMC Cancer; 2020 Mar; 20(1):270. PubMed ID: 32228636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A prognostic model of intrahepatic cholangiocarcinoma after curative intent resection based on Bayesian network].
    Chen C; Wu YH; Zhang JW; Qiu YH; Wu H; Li Q; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2021 Apr; 59(4):265-271. PubMed ID: 33706443
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
    Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
    World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
    Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
    Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
    Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
    World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.
    Buettner S; Koerkamp BG; Ejaz A; Buisman FE; Kim Y; Margonis GA; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JN; Pawlik TM
    J Surg Oncol; 2017 Mar; 115(3):312-318. PubMed ID: 28105651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.
    Song P; Midorikawa Y; Nakayama H; Higaki T; Moriguchi M; Aramaki O; Yamazaki S; Aoki M; Teramoto K; Takayama T
    Cancer Med; 2019 Oct; 8(13):5862-5871. PubMed ID: 31407490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
    Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
    JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
    BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
    Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
    JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.